UroGen Pharma Ltd.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
UroGen Pharma Ltd.
CIK #0001668243
EDGAR Form CIK 2011 - 2025
10-K [0001668243]
10-Q [0001668243]
3 [0001668243]
4 [0001668243]
6-K [0001668243]
8-K [0001668243]
D [0001668243]
SC 13D [0001668243]
SC 13G [0001668243]
Form 13D/13G Filer Form 13D/13G Subject Filed
Paradigm Biocapital Advisors LP UroGen Pharma Ltd [2025-08-12]
Morgan Stanley UroGen Pharma Ltd [2025-08-06]
Soleus Capital Master Fund LP UroGen Pharma Ltd [2025-06-16]
Cowen Financial Products LLC UroGen Pharma Ltd [2025-06-13]
Adage Capital Management LP UroGen Pharma Ltd [2024-11-12]
BlackRock Inc UroGen Pharma Ltd [2024-11-08]
Morgan Stanley UroGen Pharma Ltd [2024-11-06]
BlackRock Inc UroGen Pharma Ltd [2024-10-24]
Point72 Asset Management LP UroGen Pharma Ltd [2024-06-24]
Cowen and Company LLC UroGen Pharma Ltd [2024-06-24]
View All
Form 3/4/5 Subject 2011 - 2025
Schoenberg Mark
UroGen Pharma Ltd.
Smith Jason Drew
Barrett Elizabeth A.
Degnan Chris
Kim Dong
Cohen Fred E
Belldegrun Arie
Wildman Daniel George
Holden Stuart
Robinson James A. Jr.
Wen Leana
Butitta Cynthia M
Nussbaum Ran
Henderson Molly
Falberg Kathryn E
Tomasello Shawn
Pfreundschuh Peter P
Mullennix Stephen
Bentsur Ron
ProQuest Investments IV, L.P.
Moorin Jay
ProQuest Associates IV LLC
Schreiber Alain
Terms | Privacy | Guide
tony@aum13f.com